Atlas Trials

Evaluation of Nalmefene in Impulse Control Disorders in Parkinson's Disease: A Prospective Open Label Study

Clinical trial NCT02934919 · UNKNOWN

Trial details

NCT number
NCT02934919
Sponsor
University Hospital, Clermont-Ferrand
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Impulse Control DisordersParkinson Disease
Start date
2016-12-01
Primary completion
2018-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.